NDC 0074-2625 – Mavyret
Pibrentasvir 40 mg/1; Glecaprevir 100 mg/1 · Tablet, Film Coated · Oral
Product NDC0074-2625
Product details
- Brand name
- Mavyret
- Generic name
- Glecaprevir and Pibrentasvir
- Labeler
- AbbVie Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209394
- Marketed since
- August 3, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor
Active ingredients
- Pibrentasvir 40 mg/1
- Glecaprevir 100 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0074-2625-04 | 4 CARTON in 1 CARTON (0074-2625-04) / 7 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACK | Apr 15, 2025 |
| 0074-2625-28 | 4 CARTON in 1 CARTON (0074-2625-28) / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK | Aug 3, 2017 |
| 0074-2625-56 | 2 CARTON in 1 CARTON (0074-2625-56) / 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK | Aug 3, 2017 |
| 0074-2625-84 | 84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-84) | Jun 22, 2021 |
Other Mavyret products
- 0074-2600 Pibrentasvir 20 mg/1; Glecaprevir 50 mg/1 · Pellet · AbbVie Inc.